The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.

The CAG repeat in exon 1 of the androgen receptor (AR) genes has been postulated as both a susceptibility allele and phenotypic modifier in BRCA1-associated breast cancers. We have analysed this repeat in a set of 178 breast cancer cases who have been selected only for age of presentation at 65 year...

Full description

Bibliographic Details
Main Authors: Given, H, Radbourne, R, Oag, H, Merritt, S, Barclay, E, Hanby, A, Lamlum, H, McGrath, J, Curran, C, Tomlinson, I
Format: Journal article
Language:English
Published: 2000
_version_ 1826275138440527872
author Given, H
Radbourne, R
Oag, H
Merritt, S
Barclay, E
Hanby, A
Lamlum, H
McGrath, J
Curran, C
Tomlinson, I
author_facet Given, H
Radbourne, R
Oag, H
Merritt, S
Barclay, E
Hanby, A
Lamlum, H
McGrath, J
Curran, C
Tomlinson, I
author_sort Given, H
collection OXFORD
description The CAG repeat in exon 1 of the androgen receptor (AR) genes has been postulated as both a susceptibility allele and phenotypic modifier in BRCA1-associated breast cancers. We have analysed this repeat in a set of 178 breast cancer cases who have been selected only for age of presentation at 65 years or less. No effect of repeat length on age of presentation was found and there was no association between repeat length and family history. In combination with the data from other workers, our findings suggest that the androgen receptor repeat does not act as a modifier gene or susceptibility locus outside the context of the hereditary breast/ovarian cancer syndrome.
first_indexed 2024-03-06T22:54:08Z
format Journal article
id oxford-uuid:5fcb4e54-f097-4c2c-a99f-7daef5e598c5
institution University of Oxford
language English
last_indexed 2024-03-06T22:54:08Z
publishDate 2000
record_format dspace
spelling oxford-uuid:5fcb4e54-f097-4c2c-a99f-7daef5e598c52022-03-26T17:49:17ZThe androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5fcb4e54-f097-4c2c-a99f-7daef5e598c5EnglishSymplectic Elements at Oxford2000Given, HRadbourne, ROag, HMerritt, SBarclay, EHanby, ALamlum, HMcGrath, JCurran, CTomlinson, IThe CAG repeat in exon 1 of the androgen receptor (AR) genes has been postulated as both a susceptibility allele and phenotypic modifier in BRCA1-associated breast cancers. We have analysed this repeat in a set of 178 breast cancer cases who have been selected only for age of presentation at 65 years or less. No effect of repeat length on age of presentation was found and there was no association between repeat length and family history. In combination with the data from other workers, our findings suggest that the androgen receptor repeat does not act as a modifier gene or susceptibility locus outside the context of the hereditary breast/ovarian cancer syndrome.
spellingShingle Given, H
Radbourne, R
Oag, H
Merritt, S
Barclay, E
Hanby, A
Lamlum, H
McGrath, J
Curran, C
Tomlinson, I
The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.
title The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.
title_full The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.
title_fullStr The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.
title_full_unstemmed The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.
title_short The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.
title_sort androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer
work_keys_str_mv AT givenh theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT radbourner theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT oagh theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT merritts theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT barclaye theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT hanbya theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT lamlumh theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT mcgrathj theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT curranc theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT tomlinsoni theandrogenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT givenh androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT radbourner androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT oagh androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT merritts androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT barclaye androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT hanbya androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT lamlumh androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT mcgrathj androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT curranc androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer
AT tomlinsoni androgenreceptorexon1trinucleotiderepeatdoesnotactasamodifieroftheageofpresentationinbreastcancer